396 related articles for article (PubMed ID: 10206305)
1. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
Gonc EN; Kandemir N
Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
[TBL] [Abstract][Full Text] [Related]
4. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
[TBL] [Abstract][Full Text] [Related]
5. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
7. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
8. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
9. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
Lucidarme N; Ruiz JC; Czernichow P; Léger J
J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures.
Mitra D; Elvins DM; Collins AJ
J Rheumatol; 1999 Oct; 26(10):2201-4. PubMed ID: 10529140
[TBL] [Abstract][Full Text] [Related]
11. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
12. Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood.
Odame I; Duckworth J; Talsma D; Beaumont L; Furlong W; Webber C; Barr R
Pediatr Blood Cancer; 2006 Mar; 46(3):357-62. PubMed ID: 16035080
[TBL] [Abstract][Full Text] [Related]
13. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
14. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
[TBL] [Abstract][Full Text] [Related]
15. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
16. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in bone mineral density distribution and bone scintigraphy in patients with childhood onset hypopituitarism.
Kosowicz J; El Ali Z; Ziemnicka K; Sowinski J
J Clin Densitom; 2007; 10(3):332-9. PubMed ID: 17470407
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
[TBL] [Abstract][Full Text] [Related]
20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
